Open AccessEfficacy of lenalidomide in the treatment of myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-U) with the presence of deletion 5q– and trisomy 8+
Author(s) -
Oliwia Bachanek-Mitura,
Aneta SzudySzczyrek,
Marek Hus
Publication year - 2021
Publication title -
deleted journal
Language(s) - English
Resource type - Journals
ISSN - 2720-1015
DOI - 10.5603/hcp.2021.0004
Subject(s) - myelodysplastic syndromes , lenalidomide , thrombocytosis , medicine , juvenile myelomonocytic leukemia , chronic myelomonocytic leukemia , trisomy 8 , myeloid leukemia , gastroenterology , bone marrow , biology , cytogenetics , platelet , multiple myeloma , haematopoiesis , stem cell , genetics , gene , chromosome
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom